Sander van den Bogert

Class of:

—

Current affiliation:

Utrecht University & Apotheek Boekel

Contact: 

c.a.vandenbogert@uu.nl

Education and experience:

Sander van den Bogert obtained his PharmD degree in 2013. During his master, he was involved in clinical epidemiology research at the Center for Education & Research on Therapeutics of Musculoskeletal Disorders of the University of Alabama at Birmingham, USA (2010-2011), and in policy research at the WHO Headquarters in Geneva, Switzerland (2012).

Title PhD project:

Trials & Tribulations : Studies on the fate, transparency and efficiency of clinical drug trials

Teammembers and other people involved:

Prof. Dr. Bert Leufkens, Patrick Souverein (UU), Gerard Koëter (voormalig voorzitter CCMO), Cecile Brekelmans (CCMO), Susan Janssen (RIVM), Lex Bouter (VU)

 

Publications:

2016 

Jongen, Peter M J M, van den Bogert, Cornelis A, van de Laar, Catharina W E, Notenboom, Kim, Hille, Elysée T M & Hegger, Ingrid (21-04-2016). Risk indicator taxonomy for supervision of clinical trials on medicinal products. Current Medical Research and Opinion, (pp. 1-8) (8 p.).

2015 

Van Den Bogert, Cornelis A. & Cohen, Adam F. (22-07-2015). Need for a proactive and structured approach to risk analysis when designing phase i trials. BMJ – Clinical research, 351.

Van Den Bogert, Cornelis A., Souverein, Patrick C., Brekelmans, Cecile T M, Janssen, Susan W J, Van Hunnik, Manon, Koëter, Gerard H., Leufkens, Hubertus G M & Bouter, Lex M. (2015). Occurrence and determinants of selective reporting of clinical drug trials – Design of an inception cohort study. BMJ open, 5 (7).

2014 

van den Bogert, C.A., Wiltink, E., Vis, R., Tupker, R.A. & Schramel, F.M.N.H. (2014). Anafylactische reacties na toediening van etoposide gevolgd door paclitaxel bij een patiënte. Nederlands Tijdschrift voor Oncologie, 11 (3), (pp. 100-104) (5 p.).

van den Bogert, Cornelis A, Souverein, Patrick C, Putzeist, Michelle, Leufkens, Hubert G M, Janssen, Susan W J & Koëter, Gerard H (2014). Regulatory watch – Outcomes of EMA marketing authorization applications: does partnering have an influence?. Nature Reviews. Drug Discovery, 13 (12), (pp. 878) (1 p.).

van den Bogert, Cornelis A, Miller, Michael J, Cobaugh, Daniel J, Chen, Lang, Allison, Jeroan J & Saag, Kenneth G (2014). Screening Questions for Nonsteroidal Anti-inflammatory Drug Risk Knowledge. Patient Care, 00 (00).

2011 

Leendertse, Anne J, de Koning, Fred H P, Goudswaard, Alex N, Jonkhoff, Andries R, van den Bogert, Sander C A, de Gier, Han J, Egberts, Toine C G & van den Bemt, Patricia M L A (2011). Preventing hospital admissions by reviewing medication (PHARM) in primary care – design of the cluster randomised, controlled, multi-centre PHARM-study. BMC Health Services Research, 11, (pp. 4) (1 p.).